Alphabet Inc. Dexcom Inc Transaction History

Alphabet Inc.

$2.25 Billion
Q1 2024

A detailed history of Alphabet Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Alphabet Inc. holds 1,790,773 shares of DXCM stock, worth $213 Million. This represents 11.02% of its overall portfolio holdings.

Number of Shares

1,790,773

Previous 3,681,885 51.36%

Holding current value

$213 Million

Previous $457 Million 45.64%

% of portfolio

11.02%

Previous 22.89%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$114.22 - $140.1 $216 Million - $265 Million	-1,891,112 Reduced 51.36%	1,790,773 $248 Million
Q4 2023 Feb 08, 2024	BUY	$75.49 - $124.16 $229 Million - $376 Million	3,027,031 Added 462.25%	3,681,885 $457 Million
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $48 Million - $77 Million	-557,952 Reduced 46.01%	654,854 $61.1 Million
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $4.18 Million - $4.87 Million	-37,194 Reduced 2.98%	1,212,806 $156 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $63.7 Million - $92 Million	-750,000 Reduced 37.5%	1,250,000 $142 Million

Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $167 Million - $206 Million	-2,188,154 Reduced 52.25%	2,000,000 $161 Million
Q2 2022 Nov 14, 2022	BUY	$67.99 - $132.89 $213 Million - $417 Million	3,137,559 Added 298.65%	4,188,154 $312 Million
Q1 2022 Nov 14, 2022	BUY	$94.08 - $130.2 $32.6 Million - $45.1 Million	346,584 Added 49.23%	1,050,595 $537 Million
Q4 2021 Nov 14, 2022	SELL	$129.87 - $162.82 $13.2 Million - $16.6 Million	-101,670 Reduced 12.62%	704,011 $378 Million
Q4 2019 Nov 14, 2022	BUY	$36.62 - $57.29 $25.5 Million - $39.8 Million	695,224 Added 629.41%	805,681 $176 Million
Q4 2018 Nov 14, 2022	BUY	$26.99 - $37.37 $2.98 Million - $4.13 Million	110,457 New	110,457 $3.27 Million

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

352M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $45.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.

Account